Christopher & Banks Corp (CBK) 2.25 $CBK Christopher &

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Christopher & Banks Corp (CBK) 2.25 $CBK

Christopher & Banks Corporation Reports First Quarter Fiscal 2016 Financial Results
BusinessWire - Thu Jun 09, 5:30AM CDT
--- Comparable Sales Increase of 6.0% -
CBK: 2.25 (-0.11)

Christopher & Banks Corporation Announces Participation in the Piper Jaffray 36th Annual Consumer Conference
BusinessWire - Wed Jun 01, 5:30AM CDT
Christopher & Banks Corporation (NYSE:CBK) today announced that LuAnn Via, President and Chief Executive Officer, and Peter Michielutti, Executive Vice President, Chief Operating Officer and Chief Financial Officer, will participate in a fireside chat at the Piper Jaffray 36th Annual Consumer Conference on Wednesday, June 15, 2016 at 1:45 p.m. Eastern Time. The conference is being held June 14-15 at The New York Palace Hotel in New York City.
CBK: 2.25 (-0.11)

Christopher & Banks Corporation Announces Reporting Date for Fiscal 2016 First Quarter Results
BusinessWire - Thu May 26, 5:30AM CDT
Christopher & Banks Corporation (NYSE: CBK) today announced that it plans to report its fiscal 2016 first quarter results on Thursday, June 9, 2016, before the market opens. The Company also plans to hold a conference call to discuss its financial results at 8:30 a.m. Eastern Time on Thursday, June 9, 2016.
CBK: 2.25 (-0.11)

New Strong Sell Stocks for April 15th
Zacks Equity Research - Zacks Investment Research - Fri Apr 15, 8:30AM CDT
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List for Friday
EQIX: 370.30 (-2.91), AMD: 4.32 (-0.20), CBK: 2.25 (-0.11), SSP: 16.74 (-0.51), GLDD: 4.61 (-0.06)

Christopher & Banks Corporation Announces Withdrawal of Director Nomination
BusinessWire - Mon Apr 04, 8:28AM CDT
Christopher & Banks Corporation (NYSE: CBK), a Minnesota-based retailer of women's apparel and accessories, today announced that Bruce J. Klatsky has notified the Company that he has withdrawn his name as a director-nominee for election at the 2016 Annual Meeting, due to a conflict discovered early this morning that will prevent him from serving on the Board of Directors.
CBK: 2.25 (-0.11)

Christopher & Banks Corporation Announces Agreement with Macellum Capital Management as to Fourth New Nominee for Election at 2016 Annual Meeting of Stockholders
BusinessWire - Mon Apr 04, 5:30AM CDT
Christopher & Banks Corporation (NYSE: CBK), a Minnesota-based retailer of women's apparel and accessories, today announced that in connection with the previously announced Support Agreement with Macellum Capital Management LLC ("Macellum", the Company's Board of Directors has agreed to nominate Bruce J. Klatsky as the seventh nominee to stand for election at the Company's 2016 Annual Meeting of Stockholders ("2016 Annual Meeting". The other six nominees include three incumbent directors, Lisa Wardell (Board Chair), LuAnn Via (President and Chief Executive Officer) and William Sharpe and three new independent director candidates, Jonathan Duskin, Kent Kleeberger, and Laura Weil. The 2016 Annual Meeting is scheduled for June 30, 2016.
CBK: 2.25 (-0.11)

Active Penny Stocks To Watch Today, Thursday 3/10/2016
ACCESSWIRE - Thu Mar 10, 10:33AM CST
CORAL GABLES, FL / ACCESSWIRE / March 10, 2016 / Daily Stock Reporter is issuing a report on four stocks to watch. VCEL, MXPT, NLST, and CBK have been added to our watchlist today. Continue reading to find out why. - To get daily alerts on top stocks on the OTCQB, OTCQX, NASDAQ, NYSE, and OTCBB, subscribe to our newsletter at DailyStockReporter.com.
VCEL: 2.43 (-0.07), NLST: 1.10 (-0.01), CBK: 2.25 (-0.11), MXPT: 10.53 (-0.51)

Christopher & Banks Corporation Announces Changes to Board of Directors and Support Agreement with Macellum Capital Management
BusinessWire - Thu Mar 10, 7:30AM CST
Christopher & Banks Corporation (NYSE:CBK), a Minnesota-based retailer of women's apparel and accessories, today announced that it has entered into a Support Agreement with Macellum Capital Management LLC ("Macellum", which beneficially owns approximately 8.4% of the Company's outstanding shares. Pursuant to the Support Agreement, the Company's Board of Directors has agreed to nominate four new, independent director candidates to stand for election at the Company's 2016 Annual Meeting of Stockholders: Jonathan Duskin, Kent Kleeberger, Laura Weil and a mutually agreed upon fourth independent director. The 2016 Annual Meeting is tentatively scheduled for June 30, 2016.
CBK: 2.25 (-0.11)

Christopher & Banks reports 4Q loss
Automated Insights - Thu Mar 10, 5:47AM CST
PLYMOUTH, Minn. (AP) _ Christopher & Banks Corp. (CBK) on Thursday reported a fiscal fourth-quarter loss of $46.6 million, after reporting a profit in the same period a year earlier.
CBK: 2.25 (-0.11)

Christopher & Banks Corporation Reports Fourth Quarter Fiscal 2015 Financial Results
BusinessWire - Thu Mar 10, 5:30AM CST
Christopher & Banks Corporation (NYSE:CBK), a specialty women's apparel retailer, today reported results for the fourth quarter and fiscal year ended January 30, 2016.
CBK: 2.25 (-0.11)

Strength Seen in Christopher & Banks (CBK): Jumps 16.1%
Zacks Equity Research - Zacks Investment Research - Mon Jan 25, 7:25AM CST
Christopher & Banks Corporation (CBK) saw its shares rise over 16% on the day.
CBK: 2.25 (-0.11), ANF: 18.75 (+0.11)

Pacific Continental announces dividend of USD0.11 per share
M2 - Thu Jan 21, 3:01AM CST
The parent company of Pacific Continental Bank, Pacific Continental Corporation (Nasdaq: CBK), reported on Wednesday that its board of directors authorised a regular cash dividend of USD0.11 per share.
CBK: 2.25 (-0.11), PCBK: 16.30 (-0.13)

Christopher & Banks Corporation Reports Third Quarter Fiscal 2015 Financial Results
BusinessWire - Tue Dec 08, 5:30AM CST
Christopher & Banks Corporation (NYSE:CBK), a specialty women's apparel retailer, today reported results for the third quarter ended October 31, 2015.
CBK: 2.25 (-0.11)

Christopher & Banks Corporation Announces Reporting Date for Fiscal 2015 Third Quarter Results
BusinessWire - Tue Nov 24, 5:30AM CST
Christopher & Banks Corporation (NYSE:CBK) today announced that it plans to report its fiscal 2015 third quarter results on Tuesday, December 8, 2015, before the market opens. The Company also plans to hold a conference call to discuss its financial results at 8:30 a.m. Eastern Time on Tuesday, December 8, 2015.
CBK: 2.25 (-0.11)

Toro Set to Join the S&P MidCap 400; SPX, SPX FLOW and Core-Mark to Join the S&P SmallCap 600
PR Newswire - Mon Sep 21, 5:15PM CDT
S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 indices:
TTC: 86.45 (-2.92), SPW: 49.44 (+1.09), CBK: 2.25 (-0.11), TRAK: 63.16 (+1.05), MHFI: 107.92 (+1.16), CORE: 89.50 (-2.50)

Christopher & Banks Corporation Reports Results for the Thirteen Week Period Ended August 1, 2015
BusinessWire - Thu Sep 10, 6:30AM CDT
Christopher & Banks Corporation (NYSE:CBK), a specialty women's apparel retailer, today reported results for the thirteen week period ended August 1, 2015.
CBK: 2.25 (-0.11)

EQUITY ALERT: The Rosen Law Firm Announces Investigation of Securities Claims Against Christopher & Banks Corporation
BusinessWire - Fri Aug 14, 5:59PM CDT
The Rosen Law Firm, a global investor rights law firm, announces it is investigating potential securities claims on behalf of shareholders of Christopher & Banks Corporation (NYSE:CBK) resulting from allegations that Christopher & Banks may have issued materially misleading business information to the investing public.
CBK: 2.25 (-0.11)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RYBREVANT's Promising Results in HNSCC Treatment

Updated Category News Views 115

Impressive Outcomes for RYBREVANT FASPRO in Head and Neck Cancer Tucked away in the endless cycle of drug trials, a glimmer of hope shines through with new data on RYBREVANT FASPRO in treating head and neck squamous cell carcinoma (HNSCC). This science talk might not rattle the ticker tape directly on NYSE:JNJ, but it has all the makings of a game-changer in the oncology...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 134

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 175

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 194

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 94

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 361

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 279

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Ping An's Bold Green Moves Ahead of APEC 2026

Updated Category News Views 175

Ping An's Pitch for Green: Talking the Talk and Walking the Walk? Well, here's something cooking in Shenzhen at the Ping An Finance Center—an international seminar championing green development initiatives. It's all buzz around Ping An Insurance (HKEX: 2318; SSE: 601318) flexing its green muscle, orchestrating conversations right before APEC 2026. Talk about timing....

Continue Reading
Gildan Activewear Faces Legal Battle Over Alleged Fraud

Updated Category News Views 151

Investor Alert: Gildan's Legal Showdown Alright, here's a twist you didn't see coming—or maybe you did if you've been tracking the ticker tapes like a hawk. Gildan Activewear Inc. (NYSE:GIL) is stuck in the kind of hot water that can scald the bottom line. The Stakes: Racing Towards December 14 Marked on your calendar, December 14, is a date of some significance if...

Continue Reading
Love Business Group Helps SMEs Navigate Broadband Choices

Updated Category News Views 88

Understanding Broadband Needs for UK SMEs When you're knee-deep in running a small biz in the UK, sorting out your broadband needs can feel like sifting through a thousand-piece puzzle. Enter Love Business Group, getting a nod of recognition for being the SME knight in shining armor. Aimed at businesses of all sizes, they've been pegged by Expert Consumers for helping...

Continue Reading

Top 5 Most Recently Viewed Articles

AXIS Capital Leadership Changes Enhance Global Operations

Updated Category News Views 115

AXIS Capital Leadership Appointments for Irish Entities AXIS Capital Holdings Limited (NYSE: AXS) has taken significant steps to enhance its operational leadership. Recently, the company announced key leadership appointments for its Irish legal entities, AXIS Re SE ("ARe") and AXIS Specialty Europe SE ("ASE"). Both entities are based in Ireland and are regulated by the...

Continue Reading
AI Transformation and Market Growth in Office Supplies B2B Sector

Updated Category News Views 202

The global office stationery and supplies B2B market experienced a significant transformation driven by artificial intelligence and an uptick in business expansions. Back in 2024, the market was poised to grow by USD 20.5 billion from then to 2028, translating to a compound annual growth rate (CAGR) of 1.96%. The rising demand for environmentally friendly and recyclable...

Continue Reading
NewLake Capital Strengthens Board with Dina Rollman's Addition

Updated Category News Views 293

NewLake Capital Partners Welcomes Dina Rollman NewLake Capital Partners, Inc. (OTCQX: NLCP), a prominent provider of real estate capital to state-licensed cannabis operators, is excited to announce the recent appointment of Dina Rollman to its Board of Directors. This strategic move aims to bolster the company’s leadership as it continues to thrive in the evolving...

Continue Reading
Nasdaq Reports Surge in IPO Activity for 2025 to Date

Updated Category News Views 1069

Record Activity in Nasdaq's IPO Sphere for 2025 As the trading world gained momentum in 2025, Nasdaq showcased remarkable activity, welcoming 142 initial public offerings (IPOs) during the first half of the year. This impressive figure translated into a substantial capital raise of $19.2 billion, marking a significant resurgence in the IPO arena. Robust Listings and...

Continue Reading
Introducing ecoVerificado.com: A New Standard for Baby Diapers

Updated Category News Views 92

Revolutionizing Eco-Friendly Baby Diapers In an exciting development for the baby care industry, GreenCore Solutions Corp. has launched ecoVerificado.com, creating a brand new standard for sustainable private-label baby diapers. This initiative is a game changer for manufacturers in Latin America, enabling the production of premium ecological diapers without compromising...

Continue Reading